The JAK Inhibitors Market constitutes a dynamic therapeutic arena, driven by progressive insights into JAK–STAT pathway mechanisms governing immune function and inflammatory regulation. As scientific exploration continuously reveals novel therapeutic applications for JAK pathway targeting, key stakeholders spanning pharmaceutical enterprises, biotechnology innovators,...